---
title: "Avalon Technologies Allots 7,188 Equity Shares Under ESOP Plan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278828424.md"
description: "Avalon Technologies Allots 7,188 Equity Shares Under ESOP Plan"
datetime: "2026-03-12T06:15:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278828424.md)
  - [en](https://longbridge.com/en/news/278828424.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278828424.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/278828424.md) | [繁體中文](https://longbridge.com/zh-HK/news/278828424.md)


# Avalon Technologies Allots 7,188 Equity Shares Under ESOP Plan

Avalon Technologies Allots 7,188 Equity Shares Under ESOP Plan

### Related Stocks

- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/en/quote/BBH.US.md)
- [State Street® SPDR® S&P® Biotech ETF (XBI.US)](https://longbridge.com/en/quote/XBI.US.md)
- [ARK Genomic Revolution ETF (ARKG.US)](https://longbridge.com/en/quote/ARKG.US.md)
- [Direxion Daily S&P Biotech Bull 3X ETF (LABU.US)](https://longbridge.com/en/quote/LABU.US.md)
- [ProShares Ultra Nasdaq Biotechnology (BIB.US)](https://longbridge.com/en/quote/BIB.US.md)
- [First Trust NYSE Arca Biotech ETF (FBT.US)](https://longbridge.com/en/quote/FBT.US.md)
- [Avalo Therapeutics, Inc. (AVTX.US)](https://longbridge.com/en/quote/AVTX.US.md)
- [Avalon Holdings Corporation (AWX.US)](https://longbridge.com/en/quote/AWX.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/en/quote/PBE.US.md)
- [Avalon GloboCare Corp. (ALBT.US)](https://longbridge.com/en/quote/ALBT.US.md)
- [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/en/quote/IBBQ.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/en/quote/IBB.US.md)
- [ALPS Medical Breakthroughs ETF (SBIO.US)](https://longbridge.com/en/quote/SBIO.US.md)

## Related News & Research

- [EXCLUSIVE: Avalon Teams Up With AWS Partner To Build Automated Video Platform](https://longbridge.com/en/news/281190322.md)
- [09:00 ETDelonix Bioworks Announces Initiation of Phase 1 First-in-Human Clinical Trial of a Next-Generation MenB OMV Vaccine DX-104](https://longbridge.com/en/news/281025352.md)
- [Ultragenyx clears IND for UX016 to advance Phase 1/2 GNEM study funded by patient group](https://longbridge.com/en/news/281024362.md)
- [Avalon GAAP EPS of -$0.09, revenue of $21.48M](https://longbridge.com/en/news/279850693.md)
- [Senti Biosciences Non-GAAP EPS of -$0.53 misses by $0.06](https://longbridge.com/en/news/280788653.md)